PARKINSON'S DISEASE DEMENTIA: AT THE CROSSROADS OF α-SYNUCLEIN, TAU AND AMYLOID-β

被引：0
|
作者：
Irwin, David [1 ]
Lee, V. [1 ]
Trojanowski, J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷
关键词：
Parkinson's disease; Dementia; Neuropathology;
D O I：
10.1016/j.neurobiolaging.2014.01.070
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [31] Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's disease
    Ower, Alison K.
    Hadjichrysanthou, Christoforos
    Gras, Luuk
    Goudsmit, Jaap
    Anderson, Roy M.
    de Wolf, Frank
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2018, 33 (07) : 657 - 666
  • [32] Inhibition of amyloid-β plaque formation by α-synuclein
    Bachhuber, Teresa
    Katzmarski, Natalie
    McCarter, Joanna F.
    Loreth, Desiree
    Tahirovic, Sabina
    Kamp, Frits
    Abou-Ajram, Claudia
    Nuscher, Brigitte
    Serrano-Pozo, Alberto
    Mueller, Alexandra
    Prinz, Marco
    Steiner, Harald
    Hyman, Bradley T.
    Haass, Christian
    Meyer-Luehmann, Melanie
    NATURE MEDICINE, 2015, 21 (07) : 802 - +
  • [33] Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer's disease and synucleinopathies
    Colloby, Sean J.
    Mcaleese, Kirsty E.
    Walker, Lauren
    Erskine, Daniel
    Toledo, Jon B.
    Donaghy, Paul C.
    Mckeith, Ian G.
    Thomas, Alan J.
    Attems, Johannes
    Taylor, John-Paul
    BRAIN, 2025,
  • [34] Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
    Achim Thomzig
    Katja Wagenführ
    Martin L Daus
    Marion Joncic
    Walter J Schulz-Schaeffer
    Marc Thanheiser
    Martin Mielke
    Michael Beekes
    Acta Neuropathologica Communications, 2
  • [35] Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
    Thomzig, Achim
    Wagenfuehr, Katja
    Daus, Martin L.
    Joncic, Marion
    Schulz-Schaeffer, Walter J.
    Thanheiser, Marc
    Mielke, Martin
    Beekes, Michael
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [36] Imaging Amyloid in Parkinson's Disease Dementia and Dementia with Lewy Bodies with Positron Emission Tomography
    Brooks, David J.
    MOVEMENT DISORDERS, 2009, 24 (14) : S742 - S747
  • [37] Targeting Oligomers in Neurodegenerative Disorders: Lessons from α-Synuclein, Tau, and Amyloid-β Peptide
    Shrikanth Gadad, Bharathi
    Britton, Gabrielle B.
    Rao, K. S.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 : 223 - 232
  • [38] Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
    Parnetti, Lucilla
    Farotti, Lucia
    Eusebi, Paolo
    Chiasserini, Davide
    De Carlo, Claudia
    Giannandrea, David
    Salvadori, Nicola
    Lisetti, Viviana
    Tambasco, Nicola
    Rossi, Aroldo
    Majbour, Nour K.
    El-Agnaf, Omar
    Calabresi, Paolo
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [39] Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease
    Jonathan Vogelgsang
    Hedieh Shahpasand-Kroner
    Rebekka Vogelgsang
    Frank Streit
    Ruth Vukovich
    Jens Wiltfang
    Experimental Brain Research, 2018, 236 : 1241 - 1250
  • [40] Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease
    Espay, Alberto J.
    Lafontant, David-Erick
    Poston, Kathleen L.
    Caspell-Garcia, Chelsea
    Marsili, Luca
    Cho, Hyunkeun Ryan
    McDaniel, Colin
    Kim, Nessa
    Coffey, Christopher S.
    Mahajan, Abhimanyu
    Ezzat, Kariem
    Sturchio, Andrea
    PARKINSONISM & RELATED DISORDERS, 2021, 92 : 15 - 21
12345